Share Price and Basic Stock Data
Last Updated: February 13, 2026, 8:39 pm
| PEG Ratio | 2.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Esab India Ltd operates in the welding equipment industry, with a current market price of ₹5,747 and a market capitalization of ₹8,875 Cr. The company has demonstrated robust revenue growth, recording sales of ₹1,091 Cr in the fiscal year ending March 2023, which rose to ₹1,243 Cr in March 2024, and is projected to reach ₹1,373 Cr by March 2025. The trailing twelve months (TTM) revenue stood at ₹1,439 Cr, indicating a healthy upward trend. Quarterly sales have shown resilience, with the latest reported figure of ₹303 Cr for September 2023, slightly up from ₹298 Cr in June 2023. This reflects the company’s ability to maintain consistent sales performance despite fluctuations in the market. Overall, Esab India Ltd exhibits a strong growth trajectory, underpinned by its established market position and product offerings in the welding sector.
Profitability and Efficiency Metrics
Esab India Ltd has reported impressive profitability metrics, with a net profit of ₹208 Cr and a return on equity (ROE) of 52.3%. The company’s operating profit margin (OPM) stood at 19%, showcasing its effective cost management strategies. The profitability continued to improve, as evidenced by the operating profit of ₹62 Cr for March 2024 and ₹66 Cr for March 2025, alongside a consistent OPM hovering around 18% to 19%. The interest coverage ratio (ICR) is remarkably high at 150.19x, highlighting the company’s strong ability to meet interest obligations. Furthermore, the return on capital employed (ROCE) recorded at 70% underscores the efficient utilization of capital. These metrics position Esab India Ltd favorably against industry averages, reflecting a solid operational framework and effective management strategies.
Balance Sheet Strength and Financial Ratios
Esab India Ltd maintains a robust balance sheet with total assets amounting to ₹647 Cr and minimal borrowings of just ₹4 Cr, indicating a strong equity base and low financial leverage. The company’s reserves have increased to ₹401 Cr, reflecting retained earnings and a commitment to reinvestment. The price-to-book value (P/BV) ratio is reported at 19.37x, suggesting that the stock is trading at a premium compared to its book value, a common characteristic in high-growth sectors. The current ratio stands at 1.74, indicating good short-term liquidity, while the quick ratio of 1.26 further affirms its capability to cover immediate liabilities. Overall, these financial ratios demonstrate Esab India Ltd’s financial health, enabling it to pursue growth opportunities while maintaining fiscal prudence.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Esab India Ltd reflects a stable ownership structure, with promoters holding 73.72% of the equity. This significant stake provides strong governance and strategic direction. Foreign Institutional Investors (FIIs) have gradually increased their holdings, reaching 1.53%, while Domestic Institutional Investors (DIIs) hold 12.77%. The public shareholding is reported at 11.98%, with a total of 21,499 shareholders, indicating a broad base of retail investors. The steady retention of promoter stakes coupled with a gradual rise in institutional investments suggests robust investor confidence in the company’s long-term prospects. However, the low FII presence compared to sector norms may indicate room for improvement in attracting foreign capital.
Outlook, Risks, and Final Insight
Looking ahead, Esab India Ltd is well-positioned to capitalize on the growing demand for welding solutions, supported by its strong financial performance and efficient operations. Nevertheless, potential risks include fluctuations in raw material prices and broader economic conditions that could impact demand. Moreover, the high P/E ratio of 48.3 suggests that the stock is valued at a premium, which could lead to volatility if performance does not meet investor expectations. If the company continues to innovate and expand its market share, it could enhance its competitive advantage. Conversely, failure to adapt to market dynamics or manage costs effectively could hinder growth. Overall, Esab India Ltd’s strong fundamentals provide a solid foundation for future growth, but careful monitoring of market conditions will be essential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GEE Ltd | 376 Cr. | 72.4 | 97.9/55.2 | 38.1 | 0.00 % | 1.09 % | 4.65 % | 2.00 | |
| D&H India Ltd | 150 Cr. | 147 | 251/113 | 20.4 | 48.9 | 0.00 % | 13.5 % | 11.6 % | 10.0 |
| Esab India Ltd | 8,478 Cr. | 5,531 | 6,425/4,130 | 43.3 | 271 | 1.18 % | 70.0 % | 52.3 % | 10.0 |
| Ador Welding Ltd | 1,825 Cr. | 1,048 | 1,260/788 | 25.7 | 283 | 1.91 % | 20.3 % | 13.9 % | 10.0 |
| Industry Average | 2,707.25 Cr | 1,699.60 | 29.80 | 160.25 | 0.77% | 26.22% | 20.61% | 8.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 277 | 267 | 302 | 298 | 303 | 301 | 341 | 330 | 339 | 337 | 368 | 352 | 382 |
| Expenses | 233 | 219 | 245 | 240 | 249 | 248 | 279 | 268 | 277 | 282 | 302 | 293 | 309 |
| Operating Profit | 45 | 48 | 57 | 58 | 54 | 54 | 62 | 62 | 61 | 55 | 66 | 59 | 72 |
| OPM % | 16% | 18% | 19% | 19% | 18% | 18% | 18% | 19% | 18% | 16% | 18% | 17% | 19% |
| Other Income | 1 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 33 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 43 | 49 | 56 | 57 | 52 | 51 | 60 | 60 | 59 | 55 | 63 | 55 | 101 |
| Tax % | 26% | 25% | 26% | 25% | 26% | 26% | 26% | 26% | 27% | 26% | 24% | 26% | 22% |
| Net Profit | 32 | 36 | 42 | 42 | 38 | 38 | 44 | 44 | 43 | 40 | 47 | 41 | 79 |
| EPS in Rs | 20.73 | 23.59 | 27.19 | 27.53 | 24.95 | 24.65 | 28.75 | 28.88 | 28.04 | 26.23 | 30.81 | 26.60 | 51.45 |
Last Updated: January 1, 2026, 8:36 pm
Below is a detailed analysis of the quarterly data for Esab India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 382.00 Cr.. The value appears strong and on an upward trend. It has increased from 352.00 Cr. (Jun 2025) to 382.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Sep 2025, the value is 309.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 293.00 Cr. (Jun 2025) to 309.00 Cr., marking an increase of 16.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Jun 2025) to 72.00 Cr., marking an increase of 13.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Jun 2025) to 19.00%, marking an increase of 2.00%.
- For Other Income, as of Sep 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 32.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 55.00 Cr. (Jun 2025) to 101.00 Cr., marking an increase of 46.00 Cr..
- For Tax %, as of Sep 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 22.00%, marking a decrease of 4.00%.
- For Net Profit, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Jun 2025) to 79.00 Cr., marking an increase of 38.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 51.45. The value appears strong and on an upward trend. It has increased from 26.60 (Jun 2025) to 51.45, marking an increase of 24.85.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:24 am
| Metric | Dec 2013 | Mar 2015n n 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 434 | 552 | 451 | 466 | 543 | 672 | 698 | 681 | 896 | 1,091 | 1,243 | 1,373 | 1,439 |
| Expenses | 383 | 507 | 406 | 422 | 491 | 593 | 601 | 598 | 775 | 904 | 1,014 | 1,129 | 1,186 |
| Operating Profit | 51 | 45 | 45 | 44 | 52 | 79 | 97 | 83 | 121 | 187 | 229 | 245 | 252 |
| OPM % | 12% | 8% | 10% | 9% | 10% | 12% | 14% | 12% | 13% | 17% | 18% | 18% | 18% |
| Other Income | 8 | -0 | 6 | 4 | 11 | 16 | 14 | 11 | 5 | 8 | 6 | 8 | 39 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 2 | 2 | 3 |
| Depreciation | 11 | 14 | 10 | 10 | 10 | 11 | 13 | 12 | 11 | 12 | 14 | 15 | 16 |
| Profit before tax | 47 | 31 | 41 | 38 | 53 | 84 | 97 | 81 | 114 | 182 | 220 | 236 | 273 |
| Tax % | 30% | 23% | 31% | 29% | 29% | 32% | 27% | 26% | 26% | 26% | 26% | 26% | |
| Net Profit | 33 | 24 | 28 | 27 | 37 | 58 | 71 | 59 | 84 | 136 | 163 | 175 | 208 |
| EPS in Rs | 21.52 | 15.36 | 18.41 | 17.45 | 24.13 | 37.41 | 46.39 | 38.52 | 54.77 | 88.14 | 105.88 | 113.96 | 135.09 |
| Dividend Payout % | 5% | 7% | 5% | 6% | 4% | 241% | 151% | 114% | 110% | 88% | 81% | 79% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -3.57% | 37.04% | 56.76% | 22.41% | -16.90% | 42.37% | 61.90% | 19.85% | 7.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 40.61% | 19.72% | -34.34% | -39.32% | 59.27% | 19.53% | -42.05% | -12.49% |
Esab India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 20% |
| 3 Years: | 28% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 29% |
| 3 Years: | 13% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 43% |
| 3 Years: | 54% |
| Last Year: | 52% |
Last Updated: September 5, 2025, 3:40 am
Balance Sheet
Last Updated: December 10, 2025, 2:38 am
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 252 | 274 | 300 | 327 | 363 | 251 | 322 | 244 | 229 | 245 | 291 | 346 | 401 |
| Borrowings | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 3 | 3 | 4 | 5 | 4 | 4 |
| Other Liabilities | 83 | 80 | 70 | 85 | 102 | 112 | 116 | 126 | 189 | 210 | 240 | 282 | 216 |
| Total Liabilities | 350 | 369 | 386 | 428 | 480 | 379 | 458 | 388 | 436 | 474 | 551 | 647 | 637 |
| Fixed Assets | 96 | 83 | 78 | 76 | 80 | 83 | 86 | 90 | 90 | 95 | 125 | 136 | 140 |
| CWIP | 3 | 1 | 5 | 7 | 8 | 3 | 7 | 3 | 3 | 20 | 4 | 9 | 5 |
| Investments | 105 | 122 | 120 | 147 | 125 | 30 | 70 | 41 | 31 | 0 | 0 | 24 | 19 |
| Other Assets | 147 | 163 | 183 | 198 | 269 | 262 | 295 | 255 | 312 | 359 | 421 | 478 | 473 |
| Total Assets | 350 | 369 | 386 | 428 | 480 | 379 | 458 | 388 | 436 | 474 | 551 | 647 | 637 |
Below is a detailed analysis of the balance sheet data for Esab India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 401.00 Cr.. The value appears strong and on an upward trend. It has increased from 346.00 Cr. (Mar 2025) to 401.00 Cr., marking an increase of 55.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 216.00 Cr.. The value appears to be improving (decreasing). It has decreased from 282.00 Cr. (Mar 2025) to 216.00 Cr., marking a decrease of 66.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 637.00 Cr.. The value appears to be improving (decreasing). It has decreased from 647.00 Cr. (Mar 2025) to 637.00 Cr., marking a decrease of 10.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 136.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Sep 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 5.00 Cr..
- For Other Assets, as of Sep 2025, the value is 473.00 Cr.. The value appears to be declining and may need further review. It has decreased from 478.00 Cr. (Mar 2025) to 473.00 Cr., marking a decrease of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 637.00 Cr.. The value appears to be declining and may need further review. It has decreased from 647.00 Cr. (Mar 2025) to 637.00 Cr., marking a decrease of 10.00 Cr..
Notably, the Reserves (401.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Mar 2015n n 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 51.00 | 45.00 | 45.00 | 43.00 | 52.00 | 79.00 | 92.00 | 80.00 | 118.00 | 183.00 | 224.00 | 241.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23 | 29 | 37 | 37 | 40 | 35 | 44 | 53 | 55 | 51 | 55 | 60 |
| Inventory Days | 82 | 55 | 76 | 77 | 76 | 58 | 66 | 61 | 68 | 67 | 55 | 59 |
| Days Payable | 70 | 56 | 56 | 71 | 78 | 71 | 74 | 80 | 93 | 82 | 65 | 87 |
| Cash Conversion Cycle | 35 | 28 | 57 | 43 | 38 | 21 | 36 | 34 | 30 | 36 | 45 | 31 |
| Working Capital Days | 18 | 22 | 39 | 34 | 67 | 48 | 40 | 46 | 30 | 30 | 25 | 26 |
| ROCE % | 19% | 15% | 14% | 13% | 15% | 26% | 32% | 27% | 44% | 71% | 77% | 70% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 900,000 | 1.51 | 548.19 | 900,000 | 2025-04-22 14:12:25 | 0% |
| Nippon India Small Cap Fund | 411,697 | 0.37 | 250.76 | 326,882 | 2025-12-08 07:42:13 | 25.95% |
| SBI MNC Fund | 250,000 | 2.61 | 152.28 | N/A | N/A | N/A |
| SBI Infrastructure Fund | 166,000 | 2.14 | 101.11 | 78,374 | 2025-12-07 04:11:33 | 111.8% |
| SBI Retirement Benefit Fund - Aggressive Plan | 60,850 | 1.17 | 37.06 | 43,850 | 2025-12-07 06:25:12 | 38.77% |
| Sundaram Small Cap Fund | 53,081 | 0.95 | 32.33 | 60,184 | 2026-01-25 05:51:20 | -11.8% |
| Aditya Birla Sun Life MNC Fund | 30,533 | 0.52 | 18.6 | 27,289 | 2026-01-25 05:51:20 | 11.89% |
| SBI Retirement Benefit Fund - Aggressive Hybrid Plan | 27,100 | 0.97 | 16.51 | 42,100 | 2025-12-07 06:12:15 | -35.63% |
| Sundaram Infrastructure Advantage Fund | 25,000 | 1.61 | 15.23 | N/A | N/A | N/A |
| Sundaram Long Term Micro Cap Tax Advantage Fund - Series III | 3,065 | 2.5 | 1.87 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 113.98 | 105.90 | 88.16 | 54.78 | 38.52 |
| Diluted EPS (Rs.) | 113.98 | 105.90 | 88.16 | 54.78 | 38.52 |
| Cash EPS (Rs.) | 123.68 | 114.86 | 95.88 | 62.14 | 46.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 234.73 | 198.87 | 169.12 | 158.69 | 168.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 234.73 | 198.87 | 169.12 | 158.69 | 168.43 |
| Dividend / Share (Rs.) | 90.00 | 86.00 | 78.00 | 60.00 | 44.00 |
| Revenue From Operations / Share (Rs.) | 892.44 | 807.88 | 708.77 | 580.12 | 444.84 |
| PBDIT / Share (Rs.) | 163.95 | 152.16 | 126.37 | 81.34 | 60.20 |
| PBIT / Share (Rs.) | 154.26 | 143.20 | 118.65 | 73.98 | 52.59 |
| PBT / Share (Rs.) | 153.16 | 142.92 | 118.45 | 73.79 | 52.33 |
| Net Profit / Share (Rs.) | 113.98 | 105.90 | 88.16 | 54.78 | 38.52 |
| PBDIT Margin (%) | 18.37 | 18.83 | 17.82 | 14.02 | 13.53 |
| PBIT Margin (%) | 17.28 | 17.72 | 16.74 | 12.75 | 11.82 |
| PBT Margin (%) | 17.16 | 17.69 | 16.71 | 12.71 | 11.76 |
| Net Profit Margin (%) | 12.77 | 13.10 | 12.43 | 9.44 | 8.66 |
| Return on Networth / Equity (%) | 48.55 | 53.25 | 52.13 | 34.52 | 22.87 |
| Return on Capital Employeed (%) | 63.68 | 69.55 | 67.53 | 45.42 | 30.41 |
| Return On Assets (%) | 27.10 | 29.57 | 28.62 | 19.33 | 15.27 |
| Asset Turnover Ratio (%) | 2.29 | 2.43 | 2.40 | 2.17 | 1.62 |
| Current Ratio (X) | 1.74 | 1.75 | 1.72 | 1.81 | 2.39 |
| Quick Ratio (X) | 1.26 | 1.27 | 1.12 | 1.25 | 1.78 |
| Inventory Turnover Ratio (X) | 11.35 | 4.85 | 4.59 | 4.95 | 4.09 |
| Dividend Payout Ratio (NP) (%) | 68.43 | 71.78 | 88.49 | 118.66 | 231.06 |
| Dividend Payout Ratio (CP) (%) | 63.07 | 66.18 | 81.37 | 104.61 | 192.95 |
| Earning Retention Ratio (%) | 31.57 | 28.22 | 11.51 | -18.66 | -131.06 |
| Cash Earning Retention Ratio (%) | 36.93 | 33.82 | 18.63 | -4.61 | -92.95 |
| Interest Coverage Ratio (X) | 150.19 | 557.55 | 627.35 | 431.66 | 225.98 |
| Interest Coverage Ratio (Post Tax) (X) | 105.42 | 389.05 | 438.68 | 291.72 | 145.61 |
| Enterprise Value (Cr.) | 6919.71 | 8003.20 | 5385.84 | 4620.73 | 2719.72 |
| EV / Net Operating Revenue (X) | 5.04 | 6.44 | 4.94 | 5.18 | 3.97 |
| EV / EBITDA (X) | 27.42 | 34.18 | 27.69 | 36.91 | 29.35 |
| MarketCap / Net Operating Revenue (X) | 5.10 | 6.51 | 4.99 | 5.23 | 4.03 |
| Retention Ratios (%) | 31.56 | 28.21 | 11.50 | -18.66 | -131.06 |
| Price / BV (X) | 19.37 | 26.44 | 20.91 | 19.10 | 10.65 |
| Price / Net Operating Revenue (X) | 5.10 | 6.51 | 4.99 | 5.23 | 4.03 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 |
After reviewing the key financial ratios for Esab India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 113.98. This value is within the healthy range. It has increased from 105.90 (Mar 24) to 113.98, marking an increase of 8.08.
- For Diluted EPS (Rs.), as of Mar 25, the value is 113.98. This value is within the healthy range. It has increased from 105.90 (Mar 24) to 113.98, marking an increase of 8.08.
- For Cash EPS (Rs.), as of Mar 25, the value is 123.68. This value is within the healthy range. It has increased from 114.86 (Mar 24) to 123.68, marking an increase of 8.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 234.73. It has increased from 198.87 (Mar 24) to 234.73, marking an increase of 35.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 234.73. It has increased from 198.87 (Mar 24) to 234.73, marking an increase of 35.86.
- For Dividend / Share (Rs.), as of Mar 25, the value is 90.00. This value exceeds the healthy maximum of 3. It has increased from 86.00 (Mar 24) to 90.00, marking an increase of 4.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 892.44. It has increased from 807.88 (Mar 24) to 892.44, marking an increase of 84.56.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 163.95. This value is within the healthy range. It has increased from 152.16 (Mar 24) to 163.95, marking an increase of 11.79.
- For PBIT / Share (Rs.), as of Mar 25, the value is 154.26. This value is within the healthy range. It has increased from 143.20 (Mar 24) to 154.26, marking an increase of 11.06.
- For PBT / Share (Rs.), as of Mar 25, the value is 153.16. This value is within the healthy range. It has increased from 142.92 (Mar 24) to 153.16, marking an increase of 10.24.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 113.98. This value is within the healthy range. It has increased from 105.90 (Mar 24) to 113.98, marking an increase of 8.08.
- For PBDIT Margin (%), as of Mar 25, the value is 18.37. This value is within the healthy range. It has decreased from 18.83 (Mar 24) to 18.37, marking a decrease of 0.46.
- For PBIT Margin (%), as of Mar 25, the value is 17.28. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 17.28, marking a decrease of 0.44.
- For PBT Margin (%), as of Mar 25, the value is 17.16. This value is within the healthy range. It has decreased from 17.69 (Mar 24) to 17.16, marking a decrease of 0.53.
- For Net Profit Margin (%), as of Mar 25, the value is 12.77. This value exceeds the healthy maximum of 10. It has decreased from 13.10 (Mar 24) to 12.77, marking a decrease of 0.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 48.55. This value is within the healthy range. It has decreased from 53.25 (Mar 24) to 48.55, marking a decrease of 4.70.
- For Return on Capital Employeed (%), as of Mar 25, the value is 63.68. This value is within the healthy range. It has decreased from 69.55 (Mar 24) to 63.68, marking a decrease of 5.87.
- For Return On Assets (%), as of Mar 25, the value is 27.10. This value is within the healthy range. It has decreased from 29.57 (Mar 24) to 27.10, marking a decrease of 2.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.29. It has decreased from 2.43 (Mar 24) to 2.29, marking a decrease of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.74, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.27 (Mar 24) to 1.26, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.35. This value exceeds the healthy maximum of 8. It has increased from 4.85 (Mar 24) to 11.35, marking an increase of 6.50.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 68.43. This value exceeds the healthy maximum of 50. It has decreased from 71.78 (Mar 24) to 68.43, marking a decrease of 3.35.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 63.07. This value exceeds the healthy maximum of 50. It has decreased from 66.18 (Mar 24) to 63.07, marking a decrease of 3.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 31.57. This value is below the healthy minimum of 40. It has increased from 28.22 (Mar 24) to 31.57, marking an increase of 3.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 36.93. This value is below the healthy minimum of 40. It has increased from 33.82 (Mar 24) to 36.93, marking an increase of 3.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 150.19. This value is within the healthy range. It has decreased from 557.55 (Mar 24) to 150.19, marking a decrease of 407.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 105.42. This value is within the healthy range. It has decreased from 389.05 (Mar 24) to 105.42, marking a decrease of 283.63.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6,919.71. It has decreased from 8,003.20 (Mar 24) to 6,919.71, marking a decrease of 1,083.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.04. This value exceeds the healthy maximum of 3. It has decreased from 6.44 (Mar 24) to 5.04, marking a decrease of 1.40.
- For EV / EBITDA (X), as of Mar 25, the value is 27.42. This value exceeds the healthy maximum of 15. It has decreased from 34.18 (Mar 24) to 27.42, marking a decrease of 6.76.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.10. This value exceeds the healthy maximum of 3. It has decreased from 6.51 (Mar 24) to 5.10, marking a decrease of 1.41.
- For Retention Ratios (%), as of Mar 25, the value is 31.56. This value is within the healthy range. It has increased from 28.21 (Mar 24) to 31.56, marking an increase of 3.35.
- For Price / BV (X), as of Mar 25, the value is 19.37. This value exceeds the healthy maximum of 3. It has decreased from 26.44 (Mar 24) to 19.37, marking a decrease of 7.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.10. This value exceeds the healthy maximum of 3. It has decreased from 6.51 (Mar 24) to 5.10, marking a decrease of 1.41.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Esab India Ltd:
- Net Profit Margin: 12.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 63.68% (Industry Average ROCE: 26.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 48.55% (Industry Average ROE: 20.61%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 105.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 43.3 (Industry average Stock P/E: 29.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Welding Equipments | Plot No.13, 3rd Main Road, Industrial Estate, Chennai (Madras) Tamil Nadu 600058 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kevin J Johnson | Chairman |
| Mr. Rohit Gambhir | Managing Director |
| Mr. B Mohan | Director & CFO |
| Ms. Cauvery Dharmaraj | Independent Director |
| Mr. N Ramesh Rajan | Independent Director |
| Mr. Raja Venkataraman | Independent Director |
FAQ
What is the intrinsic value of Esab India Ltd?
Esab India Ltd's intrinsic value (as of 14 February 2026) is ₹5950.58 which is 7.59% higher the current market price of ₹5,531.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹8,478 Cr. market cap, FY2025-2026 high/low of ₹6,425/4,130, reserves of ₹401 Cr, and liabilities of ₹637 Cr.
What is the Market Cap of Esab India Ltd?
The Market Cap of Esab India Ltd is 8,478 Cr..
What is the current Stock Price of Esab India Ltd as on 14 February 2026?
The current stock price of Esab India Ltd as on 14 February 2026 is ₹5,531.
What is the High / Low of Esab India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Esab India Ltd stocks is ₹6,425/4,130.
What is the Stock P/E of Esab India Ltd?
The Stock P/E of Esab India Ltd is 43.3.
What is the Book Value of Esab India Ltd?
The Book Value of Esab India Ltd is 271.
What is the Dividend Yield of Esab India Ltd?
The Dividend Yield of Esab India Ltd is 1.18 %.
What is the ROCE of Esab India Ltd?
The ROCE of Esab India Ltd is 70.0 %.
What is the ROE of Esab India Ltd?
The ROE of Esab India Ltd is 52.3 %.
What is the Face Value of Esab India Ltd?
The Face Value of Esab India Ltd is 10.0.